nodes	percent_of_prediction	percent_of_DWPC	metapath
Abacavir—Cladribine—multiple sclerosis	0.452	1	CrCtD
Abacavir—Nucleoside Analog—Azathioprine—multiple sclerosis	0.34	1	CiPCiCtD
Abacavir—Nelarabine—Cladribine—multiple sclerosis	0.158	1	CrCrCtD
Abacavir—Cladribine—RRM1—multiple sclerosis	0.000909	1	CrCbGaD
Abacavir—ADH6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000743	0.171	CbGpPWpGaD
Abacavir—ADH6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000743	0.171	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—CYP27B1—multiple sclerosis	0.000395	0.0906	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—CYP24A1—multiple sclerosis	0.000395	0.0906	CbGpPWpGaD
Abacavir—ADK—Nucleotide metabolism—RRM1—multiple sclerosis	0.000301	0.069	CbGpPWpGaD
Abacavir—UGT1A1—Irinotecan Pathway—BCHE—multiple sclerosis	0.000202	0.0464	CbGpPWpGaD
Abacavir—ADH6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000167	0.0384	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000124	0.0285	CbGpPWpGaD
Abacavir—ADH6—Metabolism—SRM—multiple sclerosis	9.58e-05	0.022	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—POMC—multiple sclerosis	8.88e-05	0.0204	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	7.8e-05	0.0179	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CYP27B1—multiple sclerosis	6.75e-05	0.0155	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CYP24A1—multiple sclerosis	6.75e-05	0.0155	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—CYP24A1—multiple sclerosis	6.24e-05	0.0143	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—CYP27B1—multiple sclerosis	6.24e-05	0.0143	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GPC5—multiple sclerosis	6.18e-05	0.0142	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—CYP27B1—multiple sclerosis	6.15e-05	0.0141	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—CYP24A1—multiple sclerosis	6.15e-05	0.0141	CbGpPWpGaD
Abacavir—ADH6—Metabolism—RRM1—multiple sclerosis	5.12e-05	0.0117	CbGpPWpGaD
Abacavir—ADK—Metabolism—SRM—multiple sclerosis	5.12e-05	0.0117	CbGpPWpGaD
Abacavir—Anaphylactic shock—Prednisolone—multiple sclerosis	4.5e-05	0.00103	CcSEcCtD
Abacavir—Oedema—Prednisolone—multiple sclerosis	4.5e-05	0.00103	CcSEcCtD
Abacavir—Neutropenia—Methotrexate—multiple sclerosis	4.49e-05	0.00103	CcSEcCtD
Abacavir—Dizziness—Azathioprine—multiple sclerosis	4.48e-05	0.00103	CcSEcCtD
Abacavir—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	4.48e-05	0.00103	CcSEcCtD
Abacavir—Cough—Triamcinolone—multiple sclerosis	4.42e-05	0.00101	CcSEcCtD
Abacavir—Convulsion—Triamcinolone—multiple sclerosis	4.39e-05	0.00101	CcSEcCtD
Abacavir—Convulsion—Methylprednisolone—multiple sclerosis	4.38e-05	0.001	CcSEcCtD
Abacavir—Urticaria—Mitoxantrone—multiple sclerosis	4.35e-05	0.000999	CcSEcCtD
Abacavir—Body temperature increased—Mitoxantrone—multiple sclerosis	4.33e-05	0.000994	CcSEcCtD
Abacavir—Abdominal pain—Mitoxantrone—multiple sclerosis	4.33e-05	0.000994	CcSEcCtD
Abacavir—Myalgia—Triamcinolone—multiple sclerosis	4.31e-05	0.000989	CcSEcCtD
Abacavir—Vomiting—Azathioprine—multiple sclerosis	4.31e-05	0.000989	CcSEcCtD
Abacavir—Pneumonia—Methotrexate—multiple sclerosis	4.31e-05	0.000988	CcSEcCtD
Abacavir—Arthralgia—Methylprednisolone—multiple sclerosis	4.3e-05	0.000987	CcSEcCtD
Abacavir—Myalgia—Methylprednisolone—multiple sclerosis	4.3e-05	0.000987	CcSEcCtD
Abacavir—Anxiety—Methylprednisolone—multiple sclerosis	4.29e-05	0.000984	CcSEcCtD
Abacavir—Rash—Azathioprine—multiple sclerosis	4.28e-05	0.00098	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	4.27e-05	0.00098	CcSEcCtD
Abacavir—Dermatitis—Azathioprine—multiple sclerosis	4.27e-05	0.00098	CcSEcCtD
Abacavir—Depression—Methotrexate—multiple sclerosis	4.27e-05	0.000979	CcSEcCtD
Abacavir—Ill-defined disorder—Dexamethasone—multiple sclerosis	4.27e-05	0.000978	CcSEcCtD
Abacavir—Ill-defined disorder—Betamethasone—multiple sclerosis	4.27e-05	0.000978	CcSEcCtD
Abacavir—Discomfort—Triamcinolone—multiple sclerosis	4.26e-05	0.000977	CcSEcCtD
Abacavir—Discomfort—Methylprednisolone—multiple sclerosis	4.25e-05	0.000975	CcSEcCtD
Abacavir—Headache—Azathioprine—multiple sclerosis	4.25e-05	0.000974	CcSEcCtD
Abacavir—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	4.25e-05	0.000974	CcSEcCtD
Abacavir—Renal failure—Methotrexate—multiple sclerosis	4.21e-05	0.000965	CcSEcCtD
Abacavir—Stomatitis—Methotrexate—multiple sclerosis	4.17e-05	0.000957	CcSEcCtD
Abacavir—Conjunctivitis—Methotrexate—multiple sclerosis	4.16e-05	0.000955	CcSEcCtD
Abacavir—Immune system disorder—Prednisone—multiple sclerosis	4.15e-05	0.000953	CcSEcCtD
Abacavir—Malaise—Dexamethasone—multiple sclerosis	4.15e-05	0.000951	CcSEcCtD
Abacavir—Malaise—Betamethasone—multiple sclerosis	4.15e-05	0.000951	CcSEcCtD
Abacavir—Anaphylactic shock—Triamcinolone—multiple sclerosis	4.14e-05	0.000948	CcSEcCtD
Abacavir—Oedema—Triamcinolone—multiple sclerosis	4.14e-05	0.000948	CcSEcCtD
Abacavir—Vertigo—Dexamethasone—multiple sclerosis	4.13e-05	0.000947	CcSEcCtD
Abacavir—Vertigo—Betamethasone—multiple sclerosis	4.13e-05	0.000947	CcSEcCtD
Abacavir—Anaphylactic shock—Methylprednisolone—multiple sclerosis	4.13e-05	0.000946	CcSEcCtD
Abacavir—Infection—Triamcinolone—multiple sclerosis	4.11e-05	0.000942	CcSEcCtD
Abacavir—Infection—Methylprednisolone—multiple sclerosis	4.1e-05	0.00094	CcSEcCtD
Abacavir—Insomnia—Prednisolone—multiple sclerosis	4.07e-05	0.000933	CcSEcCtD
Abacavir—Alopecia—Prednisone—multiple sclerosis	4.06e-05	0.000932	CcSEcCtD
Abacavir—Hepatobiliary disease—Methotrexate—multiple sclerosis	4.05e-05	0.000929	CcSEcCtD
Abacavir—Nervous system disorder—Methylprednisolone—multiple sclerosis	4.05e-05	0.000928	CcSEcCtD
Abacavir—Hypersensitivity—Mitoxantrone—multiple sclerosis	4.04e-05	0.000926	CcSEcCtD
Abacavir—Paraesthesia—Prednisolone—multiple sclerosis	4.04e-05	0.000926	CcSEcCtD
Abacavir—Nausea—Azathioprine—multiple sclerosis	4.03e-05	0.000924	CcSEcCtD
Abacavir—Skin disorder—Methylprednisolone—multiple sclerosis	4.01e-05	0.000919	CcSEcCtD
Abacavir—Malnutrition—Prednisone—multiple sclerosis	4e-05	0.000918	CcSEcCtD
Abacavir—Convulsion—Betamethasone—multiple sclerosis	3.98e-05	0.000914	CcSEcCtD
Abacavir—Convulsion—Dexamethasone—multiple sclerosis	3.98e-05	0.000914	CcSEcCtD
Abacavir—Asthenia—Mitoxantrone—multiple sclerosis	3.93e-05	0.000902	CcSEcCtD
Abacavir—Myalgia—Betamethasone—multiple sclerosis	3.91e-05	0.000898	CcSEcCtD
Abacavir—Myalgia—Dexamethasone—multiple sclerosis	3.91e-05	0.000898	CcSEcCtD
Abacavir—Anxiety—Betamethasone—multiple sclerosis	3.9e-05	0.000895	CcSEcCtD
Abacavir—Anxiety—Dexamethasone—multiple sclerosis	3.9e-05	0.000895	CcSEcCtD
Abacavir—Discomfort—Dexamethasone—multiple sclerosis	3.87e-05	0.000887	CcSEcCtD
Abacavir—Discomfort—Betamethasone—multiple sclerosis	3.87e-05	0.000887	CcSEcCtD
Abacavir—Hypotension—Methylprednisolone—multiple sclerosis	3.86e-05	0.000884	CcSEcCtD
Abacavir—Pain—Prednisolone—multiple sclerosis	3.85e-05	0.000882	CcSEcCtD
Abacavir—Hepatitis—Methotrexate—multiple sclerosis	3.84e-05	0.000882	CcSEcCtD
Abacavir—Pharyngitis—Methotrexate—multiple sclerosis	3.81e-05	0.000875	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	3.77e-05	0.000864	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	3.76e-05	0.000862	CcSEcCtD
Abacavir—Oedema—Dexamethasone—multiple sclerosis	3.75e-05	0.000861	CcSEcCtD
Abacavir—Oedema—Betamethasone—multiple sclerosis	3.75e-05	0.000861	CcSEcCtD
Abacavir—Anaphylactic shock—Betamethasone—multiple sclerosis	3.75e-05	0.000861	CcSEcCtD
Abacavir—Anaphylactic shock—Dexamethasone—multiple sclerosis	3.75e-05	0.000861	CcSEcCtD
Abacavir—Diarrhoea—Mitoxantrone—multiple sclerosis	3.75e-05	0.00086	CcSEcCtD
Abacavir—Insomnia—Triamcinolone—multiple sclerosis	3.74e-05	0.000858	CcSEcCtD
Abacavir—Insomnia—Methylprednisolone—multiple sclerosis	3.73e-05	0.000856	CcSEcCtD
Abacavir—Infection—Betamethasone—multiple sclerosis	3.73e-05	0.000855	CcSEcCtD
Abacavir—Infection—Dexamethasone—multiple sclerosis	3.73e-05	0.000855	CcSEcCtD
Abacavir—Ill-defined disorder—Prednisone—multiple sclerosis	3.71e-05	0.000852	CcSEcCtD
Abacavir—Paraesthesia—Triamcinolone—multiple sclerosis	3.71e-05	0.000852	CcSEcCtD
Abacavir—Feeling abnormal—Prednisolone—multiple sclerosis	3.71e-05	0.00085	CcSEcCtD
Abacavir—Paraesthesia—Methylprednisolone—multiple sclerosis	3.7e-05	0.00085	CcSEcCtD
Abacavir—Anaemia—Prednisone—multiple sclerosis	3.7e-05	0.000849	CcSEcCtD
Abacavir—Dyspnoea—Triamcinolone—multiple sclerosis	3.69e-05	0.000846	CcSEcCtD
Abacavir—Nervous system disorder—Betamethasone—multiple sclerosis	3.68e-05	0.000844	CcSEcCtD
Abacavir—Nervous system disorder—Dexamethasone—multiple sclerosis	3.68e-05	0.000844	CcSEcCtD
Abacavir—Thrombocytopenia—Betamethasone—multiple sclerosis	3.67e-05	0.000843	CcSEcCtD
Abacavir—Thrombocytopenia—Dexamethasone—multiple sclerosis	3.67e-05	0.000843	CcSEcCtD
Abacavir—Erythema multiforme—Methotrexate—multiple sclerosis	3.63e-05	0.000834	CcSEcCtD
Abacavir—Malaise—Prednisone—multiple sclerosis	3.61e-05	0.000828	CcSEcCtD
Abacavir—ADK—Metabolism—CYP27B1—multiple sclerosis	3.61e-05	0.00828	CbGpPWpGaD
Abacavir—ADK—Metabolism—CYP24A1—multiple sclerosis	3.61e-05	0.00828	CbGpPWpGaD
Abacavir—Vertigo—Prednisone—multiple sclerosis	3.6e-05	0.000825	CcSEcCtD
Abacavir—Anorexia—Betamethasone—multiple sclerosis	3.58e-05	0.00082	CcSEcCtD
Abacavir—Anorexia—Dexamethasone—multiple sclerosis	3.58e-05	0.00082	CcSEcCtD
Abacavir—Urticaria—Prednisolone—multiple sclerosis	3.57e-05	0.000819	CcSEcCtD
Abacavir—Fatigue—Triamcinolone—multiple sclerosis	3.57e-05	0.000818	CcSEcCtD
Abacavir—Fatigue—Methylprednisolone—multiple sclerosis	3.56e-05	0.000816	CcSEcCtD
Abacavir—Pain—Triamcinolone—multiple sclerosis	3.54e-05	0.000811	CcSEcCtD
Abacavir—Hypotension—Dexamethasone—multiple sclerosis	3.51e-05	0.000804	CcSEcCtD
Abacavir—Hypotension—Betamethasone—multiple sclerosis	3.51e-05	0.000804	CcSEcCtD
Abacavir—Vomiting—Mitoxantrone—multiple sclerosis	3.48e-05	0.000799	CcSEcCtD
Abacavir—Immune system disorder—Methotrexate—multiple sclerosis	3.47e-05	0.000796	CcSEcCtD
Abacavir—Convulsion—Prednisone—multiple sclerosis	3.47e-05	0.000796	CcSEcCtD
Abacavir—Rash—Mitoxantrone—multiple sclerosis	3.46e-05	0.000793	CcSEcCtD
Abacavir—Dermatitis—Mitoxantrone—multiple sclerosis	3.45e-05	0.000792	CcSEcCtD
Abacavir—Chills—Methotrexate—multiple sclerosis	3.45e-05	0.000791	CcSEcCtD
Abacavir—Headache—Mitoxantrone—multiple sclerosis	3.43e-05	0.000788	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	3.42e-05	0.000784	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	3.42e-05	0.000784	CcSEcCtD
Abacavir—Arthralgia—Prednisone—multiple sclerosis	3.41e-05	0.000782	CcSEcCtD
Abacavir—Myalgia—Prednisone—multiple sclerosis	3.41e-05	0.000782	CcSEcCtD
Abacavir—Feeling abnormal—Triamcinolone—multiple sclerosis	3.41e-05	0.000782	CcSEcCtD
Abacavir—Feeling abnormal—Methylprednisolone—multiple sclerosis	3.4e-05	0.00078	CcSEcCtD
Abacavir—Anxiety—Prednisone—multiple sclerosis	3.4e-05	0.000779	CcSEcCtD
Abacavir—Alopecia—Methotrexate—multiple sclerosis	3.4e-05	0.000779	CcSEcCtD
Abacavir—Insomnia—Dexamethasone—multiple sclerosis	3.39e-05	0.000778	CcSEcCtD
Abacavir—Insomnia—Betamethasone—multiple sclerosis	3.39e-05	0.000778	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	3.39e-05	0.000776	CcSEcCtD
Abacavir—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	3.37e-05	0.000774	CcSEcCtD
Abacavir—Paraesthesia—Dexamethasone—multiple sclerosis	3.37e-05	0.000773	CcSEcCtD
Abacavir—Paraesthesia—Betamethasone—multiple sclerosis	3.37e-05	0.000773	CcSEcCtD
Abacavir—Discomfort—Prednisone—multiple sclerosis	3.37e-05	0.000772	CcSEcCtD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	3.35e-05	0.0077	CbGpPWpGaD
Abacavir—Malnutrition—Methotrexate—multiple sclerosis	3.35e-05	0.000767	CcSEcCtD
Abacavir—Hypersensitivity—Prednisolone—multiple sclerosis	3.31e-05	0.00076	CcSEcCtD
Abacavir—ADK—Metabolism—GPC5—multiple sclerosis	3.3e-05	0.00757	CbGpPWpGaD
Abacavir—Urticaria—Triamcinolone—multiple sclerosis	3.29e-05	0.000753	CcSEcCtD
Abacavir—Urticaria—Methylprednisolone—multiple sclerosis	3.28e-05	0.000752	CcSEcCtD
Abacavir—Body temperature increased—Triamcinolone—multiple sclerosis	3.27e-05	0.00075	CcSEcCtD
Abacavir—Anaphylactic shock—Prednisone—multiple sclerosis	3.27e-05	0.000749	CcSEcCtD
Abacavir—Oedema—Prednisone—multiple sclerosis	3.27e-05	0.000749	CcSEcCtD
Abacavir—Abdominal pain—Methylprednisolone—multiple sclerosis	3.26e-05	0.000748	CcSEcCtD
Abacavir—Decreased appetite—Dexamethasone—multiple sclerosis	3.26e-05	0.000748	CcSEcCtD
Abacavir—Decreased appetite—Betamethasone—multiple sclerosis	3.26e-05	0.000748	CcSEcCtD
Abacavir—Nausea—Mitoxantrone—multiple sclerosis	3.26e-05	0.000747	CcSEcCtD
Abacavir—Infection—Prednisone—multiple sclerosis	3.25e-05	0.000745	CcSEcCtD
Abacavir—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	3.24e-05	0.000743	CcSEcCtD
Abacavir—Gastrointestinal disorder—Betamethasone—multiple sclerosis	3.24e-05	0.000743	CcSEcCtD
Abacavir—Fatigue—Betamethasone—multiple sclerosis	3.23e-05	0.000742	CcSEcCtD
Abacavir—Fatigue—Dexamethasone—multiple sclerosis	3.23e-05	0.000742	CcSEcCtD
Abacavir—Pain—Dexamethasone—multiple sclerosis	3.21e-05	0.000736	CcSEcCtD
Abacavir—Pain—Betamethasone—multiple sclerosis	3.21e-05	0.000736	CcSEcCtD
Abacavir—Nervous system disorder—Prednisone—multiple sclerosis	3.2e-05	0.000735	CcSEcCtD
Abacavir—Skin disorder—Prednisone—multiple sclerosis	3.17e-05	0.000728	CcSEcCtD
Abacavir—Anorexia—Prednisone—multiple sclerosis	3.11e-05	0.000714	CcSEcCtD
Abacavir—Ill-defined disorder—Methotrexate—multiple sclerosis	3.1e-05	0.000712	CcSEcCtD
Abacavir—Anaemia—Methotrexate—multiple sclerosis	3.09e-05	0.000709	CcSEcCtD
Abacavir—Feeling abnormal—Betamethasone—multiple sclerosis	3.09e-05	0.000709	CcSEcCtD
Abacavir—Feeling abnormal—Dexamethasone—multiple sclerosis	3.09e-05	0.000709	CcSEcCtD
Abacavir—Gastrointestinal pain—Dexamethasone—multiple sclerosis	3.07e-05	0.000704	CcSEcCtD
Abacavir—Gastrointestinal pain—Betamethasone—multiple sclerosis	3.07e-05	0.000704	CcSEcCtD
Abacavir—Hypersensitivity—Triamcinolone—multiple sclerosis	3.05e-05	0.000699	CcSEcCtD
Abacavir—Hypersensitivity—Methylprednisolone—multiple sclerosis	3.04e-05	0.000697	CcSEcCtD
Abacavir—Malaise—Methotrexate—multiple sclerosis	3.02e-05	0.000692	CcSEcCtD
Abacavir—Vertigo—Methotrexate—multiple sclerosis	3.01e-05	0.000689	CcSEcCtD
Abacavir—Leukopenia—Methotrexate—multiple sclerosis	3e-05	0.000687	CcSEcCtD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	2.99e-05	0.00687	CbGpPWpGaD
Abacavir—Urticaria—Betamethasone—multiple sclerosis	2.98e-05	0.000684	CcSEcCtD
Abacavir—Urticaria—Dexamethasone—multiple sclerosis	2.98e-05	0.000684	CcSEcCtD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	2.98e-05	0.00684	CbGpPWpGaD
Abacavir—Musculoskeletal discomfort—Prednisone—multiple sclerosis	2.98e-05	0.000683	CcSEcCtD
Abacavir—Dizziness—Prednisolone—multiple sclerosis	2.97e-05	0.000682	CcSEcCtD
Abacavir—Asthenia—Triamcinolone—multiple sclerosis	2.97e-05	0.00068	CcSEcCtD
Abacavir—Abdominal pain—Dexamethasone—multiple sclerosis	2.97e-05	0.00068	CcSEcCtD
Abacavir—Body temperature increased—Dexamethasone—multiple sclerosis	2.97e-05	0.00068	CcSEcCtD
Abacavir—Abdominal pain—Betamethasone—multiple sclerosis	2.97e-05	0.00068	CcSEcCtD
Abacavir—Body temperature increased—Betamethasone—multiple sclerosis	2.97e-05	0.00068	CcSEcCtD
Abacavir—Asthenia—Methylprednisolone—multiple sclerosis	2.96e-05	0.000679	CcSEcCtD
Abacavir—Insomnia—Prednisone—multiple sclerosis	2.96e-05	0.000678	CcSEcCtD
Abacavir—ADH6—Metabolism—BCHE—multiple sclerosis	2.94e-05	0.00675	CbGpPWpGaD
Abacavir—Paraesthesia—Prednisone—multiple sclerosis	2.93e-05	0.000673	CcSEcCtD
Abacavir—Pruritus—Triamcinolone—multiple sclerosis	2.93e-05	0.000671	CcSEcCtD
Abacavir—Cough—Methotrexate—multiple sclerosis	2.92e-05	0.00067	CcSEcCtD
Abacavir—Pruritus—Methylprednisolone—multiple sclerosis	2.92e-05	0.000669	CcSEcCtD
Abacavir—Convulsion—Methotrexate—multiple sclerosis	2.9e-05	0.000665	CcSEcCtD
Abacavir—Myalgia—Methotrexate—multiple sclerosis	2.85e-05	0.000653	CcSEcCtD
Abacavir—Arthralgia—Methotrexate—multiple sclerosis	2.85e-05	0.000653	CcSEcCtD
Abacavir—Decreased appetite—Prednisone—multiple sclerosis	2.84e-05	0.000651	CcSEcCtD
Abacavir—Rash—Prednisolone—multiple sclerosis	2.84e-05	0.00065	CcSEcCtD
Abacavir—Dermatitis—Prednisolone—multiple sclerosis	2.83e-05	0.00065	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	2.83e-05	0.000649	CcSEcCtD
Abacavir—Diarrhoea—Methylprednisolone—multiple sclerosis	2.82e-05	0.000647	CcSEcCtD
Abacavir—Fatigue—Prednisone—multiple sclerosis	2.82e-05	0.000646	CcSEcCtD
Abacavir—Headache—Prednisolone—multiple sclerosis	2.82e-05	0.000646	CcSEcCtD
Abacavir—Discomfort—Methotrexate—multiple sclerosis	2.81e-05	0.000646	CcSEcCtD
Abacavir—Dizziness—Triamcinolone—multiple sclerosis	2.73e-05	0.000627	CcSEcCtD
Abacavir—ADK—Metabolism—RRM1—multiple sclerosis	2.73e-05	0.00627	CbGpPWpGaD
Abacavir—Anaphylactic shock—Methotrexate—multiple sclerosis	2.73e-05	0.000626	CcSEcCtD
Abacavir—Dizziness—Methylprednisolone—multiple sclerosis	2.73e-05	0.000626	CcSEcCtD
Abacavir—Infection—Methotrexate—multiple sclerosis	2.71e-05	0.000622	CcSEcCtD
Abacavir—Feeling abnormal—Prednisone—multiple sclerosis	2.69e-05	0.000618	CcSEcCtD
Abacavir—Asthenia—Dexamethasone—multiple sclerosis	2.69e-05	0.000617	CcSEcCtD
Abacavir—Asthenia—Betamethasone—multiple sclerosis	2.69e-05	0.000617	CcSEcCtD
Abacavir—Nervous system disorder—Methotrexate—multiple sclerosis	2.68e-05	0.000614	CcSEcCtD
Abacavir—Thrombocytopenia—Methotrexate—multiple sclerosis	2.67e-05	0.000613	CcSEcCtD
Abacavir—Gastrointestinal pain—Prednisone—multiple sclerosis	2.67e-05	0.000613	CcSEcCtD
Abacavir—Nausea—Prednisolone—multiple sclerosis	2.67e-05	0.000613	CcSEcCtD
Abacavir—Pruritus—Betamethasone—multiple sclerosis	2.65e-05	0.000609	CcSEcCtD
Abacavir—Pruritus—Dexamethasone—multiple sclerosis	2.65e-05	0.000609	CcSEcCtD
Abacavir—Skin disorder—Methotrexate—multiple sclerosis	2.65e-05	0.000608	CcSEcCtD
Abacavir—Vomiting—Triamcinolone—multiple sclerosis	2.63e-05	0.000603	CcSEcCtD
Abacavir—Vomiting—Methylprednisolone—multiple sclerosis	2.62e-05	0.000602	CcSEcCtD
Abacavir—Rash—Triamcinolone—multiple sclerosis	2.61e-05	0.000598	CcSEcCtD
Abacavir—Dermatitis—Triamcinolone—multiple sclerosis	2.6e-05	0.000597	CcSEcCtD
Abacavir—Anorexia—Methotrexate—multiple sclerosis	2.6e-05	0.000597	CcSEcCtD
Abacavir—Rash—Methylprednisolone—multiple sclerosis	2.6e-05	0.000597	CcSEcCtD
Abacavir—Dermatitis—Methylprednisolone—multiple sclerosis	2.6e-05	0.000596	CcSEcCtD
Abacavir—Urticaria—Prednisone—multiple sclerosis	2.6e-05	0.000595	CcSEcCtD
Abacavir—Headache—Triamcinolone—multiple sclerosis	2.59e-05	0.000594	CcSEcCtD
Abacavir—Headache—Methylprednisolone—multiple sclerosis	2.58e-05	0.000593	CcSEcCtD
Abacavir—Abdominal pain—Prednisone—multiple sclerosis	2.58e-05	0.000592	CcSEcCtD
Abacavir—Body temperature increased—Prednisone—multiple sclerosis	2.58e-05	0.000592	CcSEcCtD
Abacavir—Diarrhoea—Dexamethasone—multiple sclerosis	2.57e-05	0.000589	CcSEcCtD
Abacavir—Diarrhoea—Betamethasone—multiple sclerosis	2.57e-05	0.000589	CcSEcCtD
Abacavir—Hypotension—Methotrexate—multiple sclerosis	2.55e-05	0.000585	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	2.49e-05	0.000571	CcSEcCtD
Abacavir—Dizziness—Dexamethasone—multiple sclerosis	2.48e-05	0.000569	CcSEcCtD
Abacavir—Dizziness—Betamethasone—multiple sclerosis	2.48e-05	0.000569	CcSEcCtD
Abacavir—Insomnia—Methotrexate—multiple sclerosis	2.47e-05	0.000566	CcSEcCtD
Abacavir—Nausea—Triamcinolone—multiple sclerosis	2.46e-05	0.000563	CcSEcCtD
Abacavir—Paraesthesia—Methotrexate—multiple sclerosis	2.45e-05	0.000562	CcSEcCtD
Abacavir—Nausea—Methylprednisolone—multiple sclerosis	2.45e-05	0.000562	CcSEcCtD
Abacavir—Dyspnoea—Methotrexate—multiple sclerosis	2.43e-05	0.000558	CcSEcCtD
Abacavir—Hypersensitivity—Prednisone—multiple sclerosis	2.41e-05	0.000552	CcSEcCtD
Abacavir—Vomiting—Dexamethasone—multiple sclerosis	2.39e-05	0.000547	CcSEcCtD
Abacavir—Vomiting—Betamethasone—multiple sclerosis	2.39e-05	0.000547	CcSEcCtD
Abacavir—Decreased appetite—Methotrexate—multiple sclerosis	2.37e-05	0.000544	CcSEcCtD
Abacavir—Rash—Betamethasone—multiple sclerosis	2.37e-05	0.000543	CcSEcCtD
Abacavir—Rash—Dexamethasone—multiple sclerosis	2.37e-05	0.000543	CcSEcCtD
Abacavir—Dermatitis—Betamethasone—multiple sclerosis	2.36e-05	0.000542	CcSEcCtD
Abacavir—Dermatitis—Dexamethasone—multiple sclerosis	2.36e-05	0.000542	CcSEcCtD
Abacavir—Gastrointestinal disorder—Methotrexate—multiple sclerosis	2.36e-05	0.000541	CcSEcCtD
Abacavir—Fatigue—Methotrexate—multiple sclerosis	2.35e-05	0.00054	CcSEcCtD
Abacavir—Headache—Dexamethasone—multiple sclerosis	2.35e-05	0.000539	CcSEcCtD
Abacavir—Headache—Betamethasone—multiple sclerosis	2.35e-05	0.000539	CcSEcCtD
Abacavir—Asthenia—Prednisone—multiple sclerosis	2.34e-05	0.000538	CcSEcCtD
Abacavir—Pain—Methotrexate—multiple sclerosis	2.34e-05	0.000536	CcSEcCtD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	2.32e-05	0.00534	CbGpPWpGaD
Abacavir—Pruritus—Prednisone—multiple sclerosis	2.31e-05	0.00053	CcSEcCtD
Abacavir—Feeling abnormal—Methotrexate—multiple sclerosis	2.25e-05	0.000516	CcSEcCtD
Abacavir—Diarrhoea—Prednisone—multiple sclerosis	2.24e-05	0.000513	CcSEcCtD
Abacavir—Gastrointestinal pain—Methotrexate—multiple sclerosis	2.23e-05	0.000512	CcSEcCtD
Abacavir—Nausea—Dexamethasone—multiple sclerosis	2.23e-05	0.000511	CcSEcCtD
Abacavir—Nausea—Betamethasone—multiple sclerosis	2.23e-05	0.000511	CcSEcCtD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	2.17e-05	0.00498	CbGpPWpGaD
Abacavir—Urticaria—Methotrexate—multiple sclerosis	2.17e-05	0.000498	CcSEcCtD
Abacavir—Dizziness—Prednisone—multiple sclerosis	2.16e-05	0.000496	CcSEcCtD
Abacavir—Body temperature increased—Methotrexate—multiple sclerosis	2.16e-05	0.000495	CcSEcCtD
Abacavir—Abdominal pain—Methotrexate—multiple sclerosis	2.16e-05	0.000495	CcSEcCtD
Abacavir—Vomiting—Prednisone—multiple sclerosis	2.08e-05	0.000476	CcSEcCtD
Abacavir—Rash—Prednisone—multiple sclerosis	2.06e-05	0.000473	CcSEcCtD
Abacavir—Dermatitis—Prednisone—multiple sclerosis	2.06e-05	0.000472	CcSEcCtD
Abacavir—Headache—Prednisone—multiple sclerosis	2.05e-05	0.000469	CcSEcCtD
Abacavir—Hypersensitivity—Methotrexate—multiple sclerosis	2.01e-05	0.000461	CcSEcCtD
Abacavir—Asthenia—Methotrexate—multiple sclerosis	1.96e-05	0.000449	CcSEcCtD
Abacavir—Nausea—Prednisone—multiple sclerosis	1.94e-05	0.000445	CcSEcCtD
Abacavir—Pruritus—Methotrexate—multiple sclerosis	1.93e-05	0.000443	CcSEcCtD
Abacavir—Diarrhoea—Methotrexate—multiple sclerosis	1.87e-05	0.000429	CcSEcCtD
Abacavir—Dizziness—Methotrexate—multiple sclerosis	1.81e-05	0.000414	CcSEcCtD
Abacavir—ADH6—Metabolism—APOE—multiple sclerosis	1.77e-05	0.00406	CbGpPWpGaD
Abacavir—Vomiting—Methotrexate—multiple sclerosis	1.74e-05	0.000398	CcSEcCtD
Abacavir—Rash—Methotrexate—multiple sclerosis	1.72e-05	0.000395	CcSEcCtD
Abacavir—Dermatitis—Methotrexate—multiple sclerosis	1.72e-05	0.000395	CcSEcCtD
Abacavir—Headache—Methotrexate—multiple sclerosis	1.71e-05	0.000392	CcSEcCtD
Abacavir—Nausea—Methotrexate—multiple sclerosis	1.62e-05	0.000372	CcSEcCtD
Abacavir—ADK—Metabolism—BCHE—multiple sclerosis	1.57e-05	0.0036	CbGpPWpGaD
Abacavir—ADH6—Metabolism—POMC—multiple sclerosis	1.52e-05	0.00349	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—SRM—multiple sclerosis	1.51e-05	0.00348	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—POMC—multiple sclerosis	1.4e-05	0.00322	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ALB—multiple sclerosis	1.38e-05	0.00318	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CYP27B1—multiple sclerosis	1.07e-05	0.00245	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CYP24A1—multiple sclerosis	1.07e-05	0.00245	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GPC5—multiple sclerosis	9.76e-06	0.00224	CbGpPWpGaD
Abacavir—ADK—Metabolism—APOE—multiple sclerosis	9.44e-06	0.00217	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—TGFB1—multiple sclerosis	9.23e-06	0.00212	CbGpPWpGaD
Abacavir—ADK—Metabolism—POMC—multiple sclerosis	8.11e-06	0.00186	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—RRM1—multiple sclerosis	8.08e-06	0.00186	CbGpPWpGaD
Abacavir—ADK—Metabolism—ALB—multiple sclerosis	7.39e-06	0.0017	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—BCHE—multiple sclerosis	4.64e-06	0.00107	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—APOE—multiple sclerosis	2.79e-06	0.000641	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—POMC—multiple sclerosis	2.4e-06	0.000551	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ALB—multiple sclerosis	2.19e-06	0.000502	CbGpPWpGaD
